This article provides a comprehensive examination of the Bladder Cancer-Associated Protein (BLCAP) gene as a novel biomarker for predicting patient response to CTLA-4 checkpoint inhibitor therapy.
This article provides a detailed comparative analysis of B-cell maturation antigen (BCMA)-targeted immunotherapies for relapsed/refractory multiple myeloma, focusing on chimeric antigen receptor T-cell (CAR-T) therapies and bispecific T-cell engagers (BiTEs).
This article provides a comprehensive review for researchers and drug development professionals on the emerging predictive roles of BCL2, FGFR3, and YAP1 in immunotherapy outcomes.
This article provides a comprehensive guide for researchers and drug development professionals on implementing automated image analysis for quantifying Cancer Stem Cell (CSC) biomarkers.
This article provides a comprehensive overview of the latest advances in targeting the immunosuppressive adenosine pathway within the tumor microenvironment (TME).
This comprehensive guide details the Aldefluor assay for detecting ALDH enzymatic activity, a key marker for stem and progenitor cells.
This article provides a comprehensive guide for researchers and drug development professionals on applying agent-based modeling (ABM) to simulate macrophage dynamics within the tumor microenvironment (TME).
This article provides a detailed, current overview of adoptive cell transfer (ACT) protocols for solid tumor immunotherapy, targeting researchers, scientists, and drug development professionals.
This article provides a comprehensive overview of advanced adoptive cell therapies (ACT) as a strategic solution for cancers resistant to conventional immunotherapies like checkpoint inhibitors.
This article provides a comprehensive analysis for researchers and drug development professionals on the emerging role of soluble programmed death-ligand 1 (sPD-L1) variants in resistance to immune checkpoint blockade.